# Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery

> **NCT02975661** · — · UNKNOWN · sponsor: **Qidong Gaitianli Medicines Co., Ltd** · enrollment: 740 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02975661
- **Lead sponsor:** Qidong Gaitianli Medicines Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-04
- **Primary completion:** 2023-10-20
- **Final completion:** 2024-02
- **Target enrollment:** 740 (ACTUAL)
- **Last updated:** 2023-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975661, "Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02975661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*